Feb 17 () - Disc Medicine said ‌on Tuesday it ‌will pursue a traditional ​U. approval pathway for its rare disease drug ...

A kidney transplant fast track program improved waitlisting and kidney transplantation rates compared with standard care, and especially reduced disparities for Black patients. A kidney transplant ...

BioRestorative Therapies, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its BRTX-100 program for treating chronic lumbar disc disease (cLDD).

Pyxis Oncology, Inc. announced that the FDA has granted Fast Track Designation for its drug PYX-201, aimed at treating adult patients with recurrent or metastatic head and neck squamous cell carcinoma ...